Details
Description
The 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) was held remotely on September 16-17, 2020. More information on the conference can be found here.
A variety of Sentinel-related work was featured, including presentations, posters, and more. These materials have been made available below.
Event Materials
Podium/Oral Presentations
- Replication of Protocol-Based Analyses of Saxagliptin and Sitagliptin Using Sentinel Modular Programs
- Validation of an ICD-10-Based Algorithm to Identify Stillbirth in the Sentinel System
- Comparing Three Signal Identification Methods with Self-Controlled Designs
- Risk of Neuropsychiatric Adverse Events Among Montelukast Users
- Risk of Non-Melanoma Skin Cancer Associated with Hydrochlorothiazide-Containing Products in the United States
- Comparative Risk Assessment of Severe Abnormal Uterine Bleeding associated with Non-Vitamin K Oral Anticoagulants
- Use of Hydroxyprogesterone Caproate and Progesterone During the 2nd and/or 3rd Trimester Among Pregnancies with Live Birth Deliveries in the Sentinel Distributed Database
- Natural History of Coagulopathy in Patients with COVID-19 in a Real-World Electronic Health Data Network
- Validation of Claims-based Algorithms to Identify Hospitalized COVID-19 Events within the FDA Sentinel System
Posters
- Incidence of Cutaneous Small Vessel Vasculitis associated with Oral Anticoagulant Use
- Utilization of IV Iron among Pregnant Women with Live Births or Stillbirths; A Study in the Sentinel Distributed Database
- Assessing the Feasibility of Evaluating Tacrolimus use after Solid Organ Transplantation in Sentinel Distributed Database
- Incidence of Ocular Adverse Events Associated with Mometasone Implants among Patients with Nasal Polyposis
- Percutaneous Transluminal Septal Myocardial Ablation and Common Procedural Complications: A Descriptive Study
- Improving Identification of Anaphylaxis
- Asthma Maintenance Medication Users in the Sentinel System
- Utilization of Spironolactone in Patients with Reduced or Preserved Ejection Fraction Heart Failure
- Incidence of Severe Abnormal Uterine Bleeding following Oral Anticoagulant Use
- Utilization of Sacubitril/Valsartan in Real-World Settings
- Antipsychotic Medication Use among Hospitalized Infants Using Inpatient Data in FDA’s Sentinel System
- Risk of Stroke and Bleeding in Nonvalvular Atrial Fibrillation Treated with Apixaban Compared to Warfarin in the Sentinel System
- Factors Related to Sodium Glucosecotransporter 2 Inhibitor (SGLT2i) and Dipeptidyl Peptidase 4 Inhibitor (DPP4i) Dispensing among Naïve, Incident, and Prevalent New Users
- Replicating the Findings of a Medicare Study on Stroke, and Bleeding Risk in Patients using NOACs for Atrial Fibrillation in the Sentinel System
- Utilization Characteristics for Inhaled Corticosteroid-based Asthma Medications in the Sentinel System, 2008-2019
Symposia